Gene Therapy Program, Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Hum Gene Ther. 2010 Oct;21(10):1273-85. doi: 10.1089/hum.2009.223.
A recombinant adeno-associated virus serotype 2 Reference Standard Material (rAAV2 RSM) has been produced and characterized with the purpose of providing a reference standard for particle titer, vector genome titer, and infectious titer for AAV2 gene transfer vectors. Production and purification of the reference material were carried out by helper virus-free transient transfection and chromatographic purification. The purified bulk material was vialed, confirmed negative for microbial contamination, and then distributed for characterization along with standard assay protocols and assay reagents to 16 laboratories worldwide. Using statistical transformation and modeling of the raw data, mean titers and confidence intervals were determined for capsid particles ({X}, 9.18 x 10¹¹ particles/ml; 95% confidence interval [CI], 7.89 x 10¹¹ to 1.05 x 10¹² particles/ml), vector genomes ({X}, 3.28 x 10¹⁰ vector genomes/ml; 95% CI, 2.70 x 10¹⁰ to 4.75 x 10¹⁰ vector genomes/ml), transducing units ({X}, 5.09 x 10⁸ transducing units/ml; 95% CI, 2.00 x 10⁸ to 9.60 x 10⁸ transducing units/ml), and infectious units ({X}, 4.37 x 10⁹ TCID₅₀ IU/ml; 95% CI, 2.06 x 10⁹ to 9.26 x 10⁹ TCID₅₀ IU/ml). Further analysis confirmed the identity of the reference material as AAV2 and the purity relative to nonvector proteins as greater than 94%. One obvious trend in the quantitative data was the degree of variation between institutions for each assay despite the relatively tight correlation of assay results within an institution. This relatively poor degree of interlaboratory precision and accuracy was apparent even though attempts were made to standardize the assays by providing detailed protocols and common reagents. This is the first time that such variation between laboratories has been thoroughly documented and the findings emphasize the need in the field for universal reference standards. The rAAV2 RSM has been deposited with the American Type Culture Collection and is available to the scientific community to calibrate laboratory-specific internal titer standards. Anticipated uses of the rAAV2 RSM are discussed.
已制备并表征了一种重组腺相关病毒血清型 2 参考标准物质(rAAV2 RSM),旨在为 AAV2 基因传递载体的颗粒滴度、载体基因组滴度和感染性滴度提供参考标准。该参考材料的生产和纯化是通过无辅助病毒的瞬时转染和色谱纯化来进行的。纯化后的散装材料装瓶,确认无微生物污染,然后分发给全球 16 个实验室,同时提供标准检测方案和检测试剂进行特性描述。使用原始数据的统计变换和建模,确定了衣壳颗粒({X},9.18×10¹¹ 颗粒/ml;95%置信区间[CI],7.89×10¹¹ 至 1.05×10¹² 颗粒/ml)、载体基因组({X},3.28×10¹⁰ 载体基因组/ml;95%CI,2.70×10¹⁰ 至 4.75×10¹⁰ 载体基因组/ml)、转导单位({X},5.09×10⁸ 转导单位/ml;95%CI,2.00×10⁸ 至 9.60×10⁸ 转导单位/ml)和感染性单位({X},4.37×10⁹ TCID₅₀ IU/ml;95%CI,2.06×10⁹ 至 9.26×10⁹ TCID₅₀ IU/ml)的平均滴度和置信区间。进一步的分析证实,参考材料的身份为 AAV2,相对于非载体蛋白的纯度大于 94%。尽管各机构内部的检测结果相关性较强,但每个检测的定量数据中都存在明显的机构间差异趋势。即使尝试通过提供详细的方案和常见试剂来标准化检测,这种实验室间的精度和准确性相对较差的情况仍然很明显。这是第一次彻底记录实验室之间的这种差异,研究结果强调了该领域对通用参考标准的需求。rAAV2 RSM 已被美国模式培养物集存库(American Type Culture Collection)保存,可供科学界用于校准实验室特定的内部滴度标准。讨论了 rAAV2 RSM 的预期用途。